Resources

Search

Menu

Close

Resources

Contact us

Manufacturing services

Oral solid dose

Sterile injectables

Antibody-drug conjugates

Tech transfer

Manufacturing network

OSD manufacturing

SI manufacturing

ADC manufacturing

About us

Careers

Leadership team

Regulatory support

Sustainability

IP protection

Expert insights

Contract Pharma 20th Anniversary Retrospective

From CAR-T therapies and Artificial Intelligence (AI), to the enactment of the Drug Supply Chain Security Act (DSCSA), the past five years have been particularly transformative for the industry. Innovation in drug development has led to more complex and increasingly targeted therapies for smaller patient populations, particularly in the orphan disease and emerging cell and gene space, resulting in manufacturing challenges that require technically advanced solutions.

Accompanied by other industry leaders JoyL Silva, General Manager at Pfizer CentreOne, spoke with Contract Pharma to unpack the changes in the industry and outsourcing, what it looked like then, how it has evolved, and where it is today - providing insights on how business operations have evolved to accommodate changing industry needs and what we can expect for the future of the industry and outsourcing.

Read the full article here.

Loading

Success

Thank you, your submission has been received!

A CMO for therapies that define legacies

Follow us

Latest marketing updates 

Sign up

Loading

© 2025 Pfizer Inc. All rights reserved. Pfizer CentreOne is a registered trademark of Pfizer Inc. Privacy Policy | Terms of Use